Il Calcio Nei Trattamenti Depurativi Extracorporei

Lemann J. , Adams N.D. , Gray R.W. . Urinary calcium excretion in human beings. New Eng J Med 1979; 301: 535–41.

Rasmussen H. . The calcium messenger system. New Eng J Med 1986; 314: 1094–170.

Rouse D. , Suki W.N. . Renal control of extracellular calcium. Kidney Int 1990; 38: 700–8.

Bricker N.S. , Slatopolsky E. , Reiss E. , Avioli L.V. . Calcium, phosphorus and bone in renal disease and transplantation. Arch Int Med 1969; 123: 543–53.

Bricker N.S. . On the pathogenesis of the uremic state. An exposition of the “trade-off hypothesis”. New Eng J Med 1972; 286: 1093–9.

Tanaka Y. , DeLuca H.F. . The control of vitamin D by inorganic phosphorus. Arch Bio-chem Biophys 1973; 154: 566–70.

Lopez-Hilker S. , Dusso A.S. , Rapp N.S. , Martin K.J. , Slatopolsky E. . Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 1990; 259: F432–7.

Messa P. , Mioni G. , Favazza A. Acetazolamide and intestinal calcium absorption in nephrotic syndrome. In “Diuretics: Chemistry, Pharmacology and clinical application”. EDTJ B Puschett 1984; 491–3.

Adler A.J. , Ferran E. , Berlyne G.M. . Effect of inorganic phosphate on serum ionized calcium concentration in vitro: a reassessment of the trade-off hypothesis. Kidney Int 1985; 28: 932–5.

Reichel H. , Deibert B. , Schmidt Gayk H. , Ritz E. . Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant 1991; 6: 162–9.

Feinfeld D.A. , Sherwood L.M. . Parathyroid hormone and 1.25 (OH) 2D3 in chronic renal failure. Kidney Int 1988; 33: 1049–58.

Hsu C.H. , Patel S. . Factors influencing calcitriol metabolism in renal failure. Kidney Int 1990; 37: 44–50.

Slatopolsky E. , Gray R. , Adams N.D. Low levels of 1.25 (OH) 2D3 are not responsible for the development of secondary hyperparathyroidism in early renal failure. (Abstract) Kidney Int 1978; 14: 733A.

Llach F. , Massry S.G. . On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 1985; 61: 601–6.

Cremer B. , Lubbers E. , Klooker P. , Schmidt-Gayk H. , Ritz E. . Calciuric response to 1.25 (OH)2D3 in early renal failure. Mineral Electrl Metab 1985; 11: 182–5.

Mountokalakis Th , Singhella-kis P.N. , Alevizaki C.C. , Virvida-kis K. , Ikkos D.G. . Relationship between degree of renal failure and impairment of intestinal calcium absorption. Nephron 1976; 16: 20–30.

Fukagawa M. , Kaname S. , Iga-rashi T. , Ogata E. , Kurokawa K. . Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int 1991; 39: 874–81.

Messa P. , Mioni G. , Montanaro D. , Favazza A. , Adorati M. . Effect of dietary sodium intake on PTH and acid-base balance in uremia. International Congress on Nutrition in Renal Disease-Bologna. Abstract 1979; 96.

Wills M.R. , Savory J. . Aluminum poisoning: dialysis encephalopathy, osteomalacia and anemia. Lancet 1983; 2: 29–34.

Cannata J.B. , Fernandez-Soto I. , Fernandez-Menendez M.J. Role of iron metabolism in absorption and cellular uptake of aluminum. Kidney Int 1991; 39: 799–803.

Malluche H. , Faugere M.C. . Renal Bone disease 1990: an unmet challenge for the nephro-logist. Kidney Int 1990; 38: 193–211.

Andress D.L. , Howard G.A. , Birnbaum R.S. . Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma. Kidney Int 1991; 39: 942–5.

Brown E.M. , Wilkson R.E. , Eastman R.C. , Pallotta J. , Maryni-nick S.P. . Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab 1982; 54: 172–9.

Kancir C.B. , Wanscher M. , Petersen P.H. . Ionized and total calcium variation induced by hemodialysis. Nephron 1988; 48: 28–30.

Goldsmith R.S. , Furszyfer J. , Johnson W.J. , Beeler G.W. , Taylor W.F. . Calcium flux during hemodialysis. Nephron 1978; 20: 132–40.

Surian M. , Malberti F. , Farina F. . Il bilancio del calcio e del magnesio in emodiafiltrazio-ne. L'emodiafiltrazionne e i trattamenti ad alti flussi. Milano: Wichtig Editore 1989; 55–9.

Malberti F. , Surian M. , Mer-cantini F. , Marchini M. . Effects of dialysate calcium concentration changes on plasma calcium and parathyroid hormone in dialysis patients treated with calcium carbonate as a phosphate binder. Nephrol Dial Transplant 1988; 3: 565.

Malberti F. , Surian M. , Marchini M. , Minetti L. . Bilancio del calcio e variazioni intradialiti-che della calcemia in emodia-filtrazione a due camere separate (PFD) in relazione al contenuto di calcio nel dialisato e nel reinfusato. Effetto sulla funzione paratiroidea di 6 mesi di trattamento. Giorn It Nefrol 1989; 6: 249–55.

Malberti F. , Farina M. , Surian M. . Emodiafiltrazione con liquidi di reinfusione privi di calcio: rischio di ipocalcemia e di bilanci di calcio negativi. Ital J Min Electrol Metab 1990; 4: 237–43.

De Vincenzi A. , Santagostino M. , Romanini D. Dinamica del paratormone intatto im-munoreattivo e bilanci di massa del calcio in biofiltrazione senza acetato. Giorn It Nefrol 1991; 8: 129–38.

D'Amour P. , Jobin J. , Hamel L. , l'Ecuyer N. . iPTH values during hemodialysis: role of ionized Ca, dialysis membranes and iPTH assays. Kidney Int 1990; 38: 308–14.

Alfrey A.C. . Aluminum intoxication. N Eng J Med 1984; 310: 1113–25.

Pun K.K. , Ho P.W.M. , Lau P. . Effects of aluminum on the parathyroid hormone receptors of bone and kidney. Kidney Int 1990; 37: 72–8.

Sedman A.B. , Alfrey A.C. , Miller N.L. , Goodman W.G. . Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig. J Clin Invest 1987; 79: 86–92.

Goodman W.G. , O'Connor J. . Aluminum alters calcium influx and efflux from bone in vitro. Kidney Int 1991; 39: 602–7.

Morrisey J. , Rothstein M. , Mayor G. , Slatopolsky E. . Suppression of parathyroid hormone secretion by aluminum. Kidney Int 1983; 23: 699–704.

Pierides A.M. , Edwards W.G. , Cullum U. , McCall J.T. , Ellis H.A. . Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness. Kidney Int 1980; 18: 115–24.

Alfrey A.C. , Le Gendre G.R. , Kaehny W.D. . The dalysis encephalopathy syndrome: possible aluminum intossication. N Eng J Med 1976; 294: 184.

Short A.I.K. , Winney R.J. , Rob-son J.S. . Reversible microcytic hypocromic anaemia in dialysis patients due to aluminum intossication. (Abstract) Proc EDTA 1980; 17: 226.

Elliot H.L. , Dryburg F. , Fell G.S. , Sabet S. , McDougall A.I. . Aluminum toxicity during regular hemodialysis. Br Med J 1978; 1: 1101.

Ellis H.A. , McCarthy J.H. , Herrington J. . Bone aluminum in hemodialyzed patients and in rats injected with aluminum chloride: relationship to impaired bone mineralization. J Clin Path 1979; 32: 832–44.

Platts M.M. , Goode G.C. , Hi-slop J.C. . Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J 1977; 2: 657–60.

Fleming L.W. , Stewart W.K. , Fell G.S. , Halls D.J. . The effect of oral aluminum therapy on plasma aluminum levels in patients with chronic renal failure in an area with low water aluminum. Clin Nephrol 1982; 17: 222–7.

Alfrey A.C. . Gastrointestinal absorption of aluminum. Clin Nephrol 1985; 24: S84–7.

Moriniere P.H. , Roussel A. . Ta-hiri, Yubstituion of aluminum hydroxyde by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperalumi-naemia and equal control of hyperparathyroidism. Proc EDTA 1982; 19: 784–7.

Slatopolsky E. , Weerts C. , Hil-ker S.L. . Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Eng J Med 1986; 315: 157–61.

Gonella M. , Calabrese G. , Vagelli G. , Pratesii G. , Lamon S. , Talarico S. . Effects of high Ca-CO3 supplements on serum calcium and phosphorus in patients on regular hemodialysis treatment. Clin Nephrol 1985; 24: 147–50.

Fournier A. , Moriniere P. , Se-bert J.L. . Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia and hyperparathyroidism in uremia. Kidney Int 1986; S18: 114–9.

Adorati M. , Gropuzzo M. , Messa P. L'uso del carbonato di calcio come chelante del fosforo nei pazienti uremici in trattamento emodialitico: confronto con l'idrossido di alluminio. G Ital Metab Min E-lettrol 1989; 3: 33–8.

Schaefer K. , Scheer J. , Asmus G. , Umlauf E. , Hagemann J. , von Herrath D. . The treatment of uraemic hyperphosphatae-mia with calcium acetate and calcium carbonate: a comparative study. Nephrol Dial Transplant 1991; 6: 170–5.

Malberti F. , Surian M. , Mar-cantini F. , Marchini M. . Effects of dialysate calcium and PTH in dialysis patients treated with calcium carbonate as a phosphate binder, (Abstracts EDTA-ERA), Madrid 1988; 239.

Kumar R. . The metabolism and mechanism of action of 1.25-dihydroxyvitamin D3. Kidney Int 1986; 30: 793–803.

Cantley L.K. , Russel J. , Lettieri D. , Sherwood L.M. . 1.25-dihydroxyvitamin D3 suppresses PTH secretion from bovine parathyroid cells in tissue culture. Endocrinology 1985; 117: 2114–9.

Russel J. , Lettieri D. , Sherwood L.M. . Suppression by 1.25 (OH)2D3 of transcription of the parathyroid hormone gene. Endocrinology 1986; 119: 2864–6.

Sugimoto T. , Ritter C. , Ried I. , Morrisey J. , Slatopolsky E. . Effect of 1,25(OH)2D3 on cyto-solic calcium in dispersed bovine parathyroid cells. Kidney Int 1988; 33: 349.

Merke J. , Szabo A. , Beier E. , Ritz E. . 1,25(OH)2D3 prevents parathyroid cell proliferation in uremic rats. Kidney Int 1988; 33: 345.

Delmez J.A. , Tindira C. , Grooms P. , Dusso A. , Windus D.W. , Slatopolsky E. . Parathyroid hormone suppression by inravenous 1,25-dihydroxyvitamin D. J Clin Invest 1989; 83: 1349–55.

Dunlay R. , Rodriguez M. , Felsenfeld A.J. , Llach F. . Direct inhibitory effect of calcitriol on parathyroid function (sigmoi-dal curve) in dialysis. Kidney Int 1989; 35: 1093–8.

Muramoto H. , Haruki K. , Yo-shimura A. , Mimo N. , Oda K. , Tofuku Y. . Treatment of refractory hyperparathyroidism in patients on hemodialysis by intermittent oral administration of 1,25(OH)2 Vitamin D3. Nephron 1991; 58: 288–94.

Kraut J.A. , Shinaberger J.H. , Singer F.R. Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia. Kidney Int 1983; 23: 725–30.

Voigts A. , Felsenfeld A.J. , Andress D. , Llach F. . Parathyroid hormone and bone hystology: response to hypocalcemia in osteitis fibrosa. Kidney Int 1984; 25: 445–52.

Felsenfeld A.J. , Rodriguez M. , Dunlay R. , Llach F. . A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodistrophy. Nephrol Dial Transplant 1991; 6: 244–51.